Literature DB >> 29202145

The benefits of physician-pharmacist collaboration.

Andrew Y Hwang1, Tyler H Gums2, John G Gums3.   

Abstract

Over the past decade, physician-pharmacist collaborative practices have gained traction in primary care as a way to implement team-based-care models. And there is evidence pointing to the effectiveness of this multidisciplinary heath care team approach, in which pharmacists are typically responsible for such things as obtaining medication histories, identifying barriers to adherence, and adjusting medication regimens. Several studies have shown the significant impact that physician-pharmacist collaborative management (PPCM) can have on blood pressure control among patients with hypertension. Additionally, PPCM may have positive effects on HbA1c reduction and diabetes control, suggesting that benefits may extend to other chronic diseases, too.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29202145

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  22 in total

1.  A physician-pharmacist collaborative care model to prevent opioid misuse.

Authors:  Pooja Lagisetty; Alex Smith; Derek Antoku; Suzanne Winter; Michael Smith; Mary Jannausch; Hae Mi Choe; Amy S B Bohnert; Michele Heisler
Journal:  Am J Health Syst Pharm       Date:  2020-05-07       Impact factor: 2.637

2.  Impact of Collaborative Inpatient Pairing Between Pharmacy Students and Family Medicine Residents on Perceptions of Interprofessional Care.

Authors:  Becky S Linn; Benjamin Elliot Yelnosky Smith; Tanner Cassel
Journal:  PRiMER       Date:  2022-05-25

3.  A Clinical Decision Support System for Diabetes Patients with Deep Learning: Experience of a Taiwan Medical Center.

Authors:  Ting-Ying Chien; Hsien-Wei Ting; Chih-Fang Chen; Cheng-Zen Yang; Chong-Yi Chen
Journal:  Int J Med Sci       Date:  2022-06-13       Impact factor: 3.642

4.  Diabetes, Therapeutic Inertia, and Patients' Medication Experience.

Authors:  Andrew S Bzowyckyj; John E Begert
Journal:  Diabetes Spectr       Date:  2020-02

5.  Changes in chronic medication adherence, costs, and health care use after a cancer diagnosis among low-income patients and the role of patient-centered medical homes.

Authors:  Lisa P Spees; Stephanie B Wheeler; Xi Zhou; Krutika B Amin; Christopher D Baggett; Jennifer L Lund; Benjamin Y Urick; Joel F Farley; Katherine E Reeder-Hayes; Justin G Trogdon
Journal:  Cancer       Date:  2020-08-11       Impact factor: 6.860

6.  Consultant Pharmacist⁻Provider Collaboration in U.S. Assisted Living Facilities: A Pilot Study.

Authors:  Kenneth C Hohmeier; Kelsey D Frederick; Krishna Patel; Kristi Summers; Morgan Honeycutt
Journal:  Pharmacy (Basel)       Date:  2019-02-01

7.  Trends in Clinical Pharmacist Integration in Family Medicine Residency Programs in North America.

Authors:  Jennie B Jarrett; Jody L Lounsbery
Journal:  Pharmacy (Basel)       Date:  2020-07-24

8.  A De Novo Pharmacist-Family Physician Collaboration Model in a Family Medicine Clinic in Alberta, Canada.

Authors:  Hoan Linh Banh; Andrew J Cave
Journal:  Pharmacy (Basel)       Date:  2021-05-28

9.  Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients - study protocol for a randomized controlled trial.

Authors:  Alexandra Halalau; Daniel Shelden; Scott Keeney; Jaspreet Hehar
Journal:  Trials       Date:  2018-08-24       Impact factor: 2.279

10.  Partnering With Pharmacists to Reduce Cardiovascular Risk in Outpatient Settings.

Authors:  Andrew Y Hwang; Steven M Smith
Journal:  J Am Heart Assoc       Date:  2019-11-12       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.